Image

Middle East and Africa Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Middle East and Africa Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Jan 2023
  • MEA
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Middle East and Africa Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 140.70 USD Million
Diagram Market Size (Forecast Year) USD 200.10 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Middle East and Africa Alopecia Treatment (Hair Loss) Market, By Disease Type (Non‒Cicatricial Alopecia, Traction Alopecia, Ciatricial Alopecia, Others), Treatment (Localized Therapies, Medical Devices, Systemic Therapies, Herbal Treatment), Gender (Male, Female), Form (Topical, Oral, Parenteral), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.

Middle East and Africa Alopecia Treatment (Hair Loss) Market

 Middle East and Africa Alopecia Treatment (Hair Loss) Market Analysis and Size

With every passing decade, hair loss is becoming more prevalent as a result of unhealthy eating habits and sedentary lifestyles. Additionally, hair loss is caused by ageing and hormonal imbalance and a rise in chronic diseases, including cancer, hypertension, arthritis, and depression, mainly among the middle-aged population. According to the American Hair Loss Association, androgenetic alopecia results for nearly 95% of hair loss in men. More than 800,000 people globally are looking for a solution to their hair loss.

Data Bridge Market Research analyses a growth rate in the alopecia treatment (hair loss) market in the forecast period 2023-2030. The expected CAGR of alopecia treatment (hair loss) market is tend to be around 4.5% in the mentioned forecast period. The market was valued at USD 140.7 million in 2022, and it would grow up to USD 200.1 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Middle East and Africa Alopecia Treatment (Hair Loss) Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Disease Type (Non‒Cicatricial Alopecia, Traction Alopecia, Ciatricial Alopecia, Others), Treatment (Localized Therapies, Medical Devices, Systemic Therapies, Herbal Treatment), Gender (Male, Female), Form (Topical, Oral, Parenteral), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)

Market Players Covered

Johnson & Johnson Private Limited (U.S.), GSK plc (U.K.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Cipla Inc. (U.S.), Endo International plc (Ireland), Zydus Group (India), Abbott (U.S.), Aurobindo Pharma (India), Dr. Reddy’s Laboratories Ltd. (India), Perrigo Company plc (Ireland), Curallux, LLC. (U.S.), DR. KURT WOLFF GMBH & CO. KG (Germany), WOCKHARDT (India)

Market Opportunities

  • Wide Adoption of Platelet-Rich Plasma Therapy
  • Increasing Adoption of Organic Hair Products

Market Definition

Alopecia is a kind of hair loss that is caused by particular medical illnesses or nutritional disorders. Hair loss is becoming more prevalent as a result of sedentary lifestyles and unhealthy eating habits. Additionally, hair loss is caused by ageing and hormonal imbalance and a rise in chronic diseases, including cancer, hypertension, arthritis, and depression, mainly among the middle-aged population. According to the American Hair Loss Association, androgenetic alopecia results for nearly 95% of hair loss in men. More than 800,000 people globally are looking for a solution to their hair loss.   

Middle East and Africa Alopecia Treatment (Hair Loss) Market Dynamics

Drivers

  • Increasing Incidence of Hair Loss

The increasing prevalence of hair loss is projected to boost the growth of the alopecia treatment (hair loss) market. For instance, rates of alopecia areata range between 6.5% 10 and 13.8%. The regions with the greatest changes in the occurrence of alopecia areata from 1990 to 2019 were Central Sub-Saharan Africa (1.47) and Western Sub-Saharan Africa (1.47), while the region with the smallest change was Central Europe (−0.04). Moreover, the age-standardized alopecia areata prevalence rates and their trends varied among diverse countries. Additionally, nearly 2% of the entire population, irrespective of gender, is at high risk of acquiring alopecia treatment (hair loss) in their lifetime. Further statistics from health departments witness that MEA’s urban residents' consumption of hair care is increasing each year at an increasing pace of 30 %, which over the upcoming years, is anticipated to increase the hair nutrition, restoration, and transplantation business. Thus, it boosts the market growth.

Opportunities

  • Wide Adoption of Platelet-Rich Plasma Therapy

Increasing adoption of platelet-rich plasma therapy is anticipated to offer huge growth opportunities for players in the market. For instance, several researchers from Plastic and Reconstructive Surgery, “Tor Vergata” University, Italy, stated that platelet-rich plasma is considered a safe and effective alternative to treat hair loss compared with Minoxidil and Finasteride in April 2020. Thus, this boosts the market growth.   

  • Increasing Adoption of Organic Hair Products

Traditional natural and herbal based products are more incident for the treatment of hair loss problems in countries such as India and China. The organic hair loss products are most likely to be pushed by males, because they are more susceptible to hair losses. In general, the hair type among middle-east people is not quite so vulnerable to genetic thinning as western hair, but that yet affects a million men and women with hair losses. Thus, it increases the market growth.

Restraints/Challenges

  • Limited Efficacy of Hair Loss Drugs

Limited efficacy and lack of evidence suggest that clinical efficacy of the existing hair loss drugs is hindering market growth. For instance, current topical hair loss treatments are widely available in the market such as minoxidil are not 100% effective for the treatment of alopecia, although it has been clinically proven to decrease the progression of hair loss.

  • Lack of Reimbursement Policies

There is a lack of reimbursement for hair loss treatment services, which are expected to restrict the market growth. Both public and private payers do not reimburse majority of the laser treatment services. The cost of such services varies greatly and there cannot be any standardization.

This alopecia treatment (hair loss) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the alopecia treatment (hair loss) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In 2019, Pfizer Inc. announced the initiation of Phase IIB/III clinical studies for its oral JAK3 inhibitor molecule PF-06651600 which is used for the treatment of alopecia areata. In 2018, the product also got breakthrough designation for the alopecia areata.

Middle East and Africa Alopecia Treatment (Hair Loss) Market Scope

The alopecia treatment (hair loss) market is segmented on the basis of disease type, treatment, gender, form, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type

  • Non‒Cicatricial Alopecia
  • Traction Alopecia
  • Ciatricial Alopecia
  • Others

Treatment

  • Localized Therapies
  • Medical Devices
  • Systemic Therapies
  • Herbal Treatment

Gender

  • Male
  • Female

Form

  • Topical
  • Oral
  • Parenteral

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Alopecia Treatment (Hair Loss) Regional Analysis/Insights

The alopecia treatment (hair loss) market is analyzed and market size insights and trends are provided by disease type, treatment, gender, form, end user and distribution channel as referenced above.

The major countries covered in the alopecia treatment (hair loss) market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Germany is leading the market growth rate due to the increased awareness among the population about the huge benefits of natural and organic products and the wide effects of harmful chemicals in the existing ones. Besides that, the rise in the population stating the issue or problem of hair loss among them is also driving the market's growth.   

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Middle East and Africa Alopecia Treatment (Hair Loss) Share Analysis

The alopecia treatment (hair loss) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, middle east and africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to alopecia treatment (hair loss) market

Key players operating in the alopecia treatment (hair loss) market include:

  • Johnson & Johnson Private Limited (U.S.)
  • GSK plc (U.K.)
  • Merck & Co., Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Cipla Inc. (U.S.)
  • Endo International plc (Ireland)
  • Zydus Group (India)
  • Abbott (U.S.)
  • Aurobindo Pharma (India)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Perrigo Company plc (Ireland)
  • Curallux, LLC. (U.S.)
  • DR. KURT WOLFF GMBH & CO. KG (Germany)
  • WOCKHARDT (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Middle East and Africa Alopecia Treatment (Hair Loss) Market is projected to grow at a CAGR of 3.25% during the forecast period by 2030.
The future market value of the Middle East and Africa Alopecia Treatment (Hair Loss) Market is expected to reach USD 16.39 million by 2030.
The major players in the Middle East and Africa Alopecia Treatment (Hair Loss) Market are Johnson & Johnson Private Limited (U.S.), GSK plc (U.K.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Cipla Inc. (U.S.), etc.
The countries covered in the Middle East and Africa Alopecia Treatment (Hair Loss) Market are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials